← FDA Drug Approvals (Drugs@FDA)
AMPHOTERICIN B
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: QILU PHARM HAINAN · Approved 2026-10-14
Drug application
- FDA Application #
ANDA220139- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- AMPHOTERICIN B
- Generic name
- Amphotericin B
- Active ingredients
- AMPHOTERICIN B
- Dosage form
- INJECTABLE, LIPOSOMAL
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- QILU PHARM HAINAN
- First approval
- 2026-10-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown